Bolus Calculator Safety Mandates a Need for Standards.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. The success of insulin pump therapy: importance of education of patients and health professionals.Frontiers in clinical diabetes and healthcare · 2024
   Article
2. Improving patient self-care using diabetes technologies.Therapeutic advances in endocrinology and metabolism · 2019
   Review
3. Advances in Care for Insulin-Requiring Patients Without Closed Loop.Diabetes technology & therapeutics · 2018
   Article
4. Bolus Advisors: Sources of Error, Targets for Improvement.Journal of diabetes science and technology · 2018
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as